Samsung revealed the Exynos 9810 chipset at the beginning of 2018, but everyone is already talking about 5G development. Qualcomm, as previously reported, will unveil a 5G Snapdragon modem next year and will start employing it into smartphones. According to the latest information, though, Samsung’s in-house Exynos platform is heading that way as well with the Exynos 9820. According to the leak, a Samsung Electronics employee is working on the Exynos 9820 project since January 2018 on various tasks like CPU validation, Debug architecture and solving issues. The same worker is also…
A scientific journal just retracted a controversial study that claimed the gene editing tool CRISPR causes a number of unintended mutations, but it may be too late to undo the damage the paper caused.
Let’s walk it back a second. In May 2017, well-respected journal Nature Methods published a peer-reviewed study from Columbia University Medical Center (CUMC). The study claimed that the gene-editing technology CRISPR caused more than a thousand unintended genetic mutations in mice — way more than any other study noted.
If that were true, it would mean that CRISPR’s potential to treat conditions in humans, from congenital blindness to cancer, would have disappeared. And the millions poured into researching CRISPR would have been wasted.
The reaction was swift and brutal for those who still had faith that CRISPR could fulfill its promise. The stocks of the three biggest gene-editing companies — CRISPR Therapeutics, Editas Medicine, and Intellia Therapeutics — all took major hits.
Except the study wasn’t actually all that legitimate.
Shortly after Nature Methods published the paper, other CRISPR researchers began pointing out its flaws, calling upon the journal to retract the study. Nature Methods responded with an Editorial Note on June 14 highlighting these criticisms. Then, on July 25, it published an Editorial Expression of Concern saying it was investigating the authors’ interpretation that gene editing causes mutations.
Now, more than 10 months later, the publication has officially retracted the paper. On March 30, Nature Methods published an editorial noting the retraction and the primary reason behind it: “There was insufficient data to support the claim of unexpected off-target effects due to CRISPR.” There could be a few different reasons for that, as one researcher previously noted on Twitter:
Their hypothesis on #CRISPR causes lots of off targets not substantiated. In short this is a terrible paper
— Gaetan Burgio (@GaetanBurgio) May 30, 2017
The experts that had opposed the paper’s original findings were vindicated; the journal also published five expert critiques of the study.
So the misinformation was corrected (though, strangely, several of the study’s original authors did not agree to the retraction, as the notice points out). The system of scientific publishing still works, and errors were rapidly remedied.
All good, right? No harm done?
Perhaps not. There are some bells you just can’t un-ring, especially when questionable studies confirm people’s fears about a particular advance. The purported link between vaccines and autism persists, no matter that the paper that started it all was retracted, and no matter how many times researchers debunk it.
Gene editing in humans was already controversial before the Nature Methods study. Skeptics warned of a future filled with “designer babies” and increased income inequality. And that was all assuming that the technology actually worked. If they were looking for “proof” that CRISPR was dangerous, they now had a scientific study to bolster their claim.
Even with the retraction, that “proof” that gene editing causes mutations is already out in the ether. It’ll stick in some people minds, no doubt.
Some scientists, including Harvard geneticist George Church, weren’t worried about the dip in stock prices. “This seems like a great example of rapidly self-correcting science… I was never worried. Some investors look for opportunities to sell high then buy back low and then watch the rebound — based more on herd psychology than lab science,” Church told publishing watchdog Retraction Watch.
But scientists don’t just need to agree that CRISPR is safe and effective in humans. They also have to convince the public that it is, and that’s much harder to do when respected journals present flawed conclusions about gene editing as fact.
The post A Journal Retracted A Controversial Paper About CRISPR. The Damage Might Already Be Done. appeared first on Futurism.
Neither April has arrived yet, nor Google has announced details for the April security update. However, that isn’t stopping Samsung from rolling out the patch, which has already started hitting Galaxy J3 (2017) units in some markets. Specifically, Netherlands and Luxembourg are the regions where the update is currently live. Needless to say, there’s currently no information on what all issues are fixed in the patch. Given the roll out has just begun, it may take time for the notification to pop up on your handset’s screen, so be patient. Via
By now, you probably know exactly what to expect from a smartphone sequel with an S in its name: it'll be faster than its predecessor but its design won't change very much. That's not necessarily a bad thing for Xiaomi's newly announced Mi Mix 2S, th…
Engadget RSS Feed
It has been a week since the bombshell reports on Cambridge Analytica's use of Facebook user data dropped and already the social media giant is facing at least four lawsuits. Along with a class action suit filed earlier this week on behalf of Faceboo…
Engadget RSS Feed
We’re still far away from the 2019 opening of Star Wars: Galaxy’s Edge, the twin expansion lands that will be opening at both Disneyland and Walt Disney World, but the narrative groundwork for the new parks is already being quietly set up. Specifically, the new novel Thrawn: Alliances from Timothy Zahn will send Darth Vader and the Grand Admiral together on a mission to Batuu, which io9 notes is the same planet that will serve as the setting for Galaxy’s Edge.
Disney hasn’t revealed too much about the planet — only that it’s a remote trading port, and “one of the last stops before Wild Space” — but taking the chance to build out the lore before the park opens is a smart way to get fans interested ahead of time. Thrawn is already a…
Have you been struggling to play Sea of Thieves since it launched on March 20th? There's a good explanation for it. In a launch update, Rare's Craig Duncan and Joe Neate have revealed that over 1 million unique gamers have played the online pirate…
Engadget RSS Feed
Equipment maker Technogym said on Tuesday that it now has over 5,000 GymKit-ready cardio machines deployed worldwide, just months after its equipment became the first with the platform in a real-world gym.
AppleInsider – Frontpage News
The Nest Hello’s only been out for a few days, and it was just added to the Google Store earlier today. But it turns out that a seller on Rakuten has been offering Hello units for just $ 177.65 a pop, which is surprising to see for a brand-new product. But if you want one, you’d better hurry; there are only five hours left to take advantage of the deal.
[Deal Alert] Nest Hello smart doorbell already down to $ 177.65 ($ 51.35 off) on Rakuten with code was written by the awesome team at Android Police.
In January, Apple announced plans to build a new campus in the United States. However, it hasn’t previously said much about AC3, its third major campus development already nearing completion in Silicon Valley. Here’s a look at the more immediate growth occurring in Apple’s backyard as the company works to accommodate an expansion of workers.
AppleInsider – Frontpage News